Wednesday, July 8, 2026

pharma · Advanced Solid Tumor · Hepatocellular Carcinoma

Coherus Oncology

Coherus Oncology trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.

333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US HQ
2010 Founded
212 Employees
NMPA registrant Type
Company details
Status
Public
HQ
333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US
Founded
2010
Employees
212
Programs
25
Drugs
11
Patents
73
Intelligence · Clinical Trials

Coherus Oncology clinical trials

Registry index of 25 ClinicalTrials.gov studies linked to Coherus Oncology programs — each row shows trial ID, program name, phase, status, and indication.

Coherus Oncology trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Coherus Oncology.

  1. Toripalimab-tpzi — Phase 2

    Clinical update
  2. Toripalimab — Phase 2

    Clinical update
  3. Toripalimab — Approved

    Clinical update
  4. Toripalimab — Phase 2

    Clinical update
  5. Toripalimab — Phase 2

    Clinical update
  6. Toripalimab + Chemotherapy — Phase 2

    Clinical update
  7. STC-15 in combination with toripalimab — Phase 2

    Clinical update
  8. NY-ESO-1 Peptide vaccine — Phase 2

    Clinical update

Trial registry

25 studies